Chronic hepatitis C viral infection can lead to cirrhosis and hepatocellular carcinoma. It is generally believed that hepatitis C infection is not oncogeneic per se, but that the presence of cirrhosis ...

‘Evidence based medicine’ is a paradigm introduced in the 1990s in which collection of clinical data in a reproducible and unbiased way is intended to guide clinical decision-making. This paradigm has ...

Researchers open the way for improved study of hepatitis C virus by devising a novel virus culture system that allows replication of patient-isolated virus in nontransformed hepatocytes, instead of ...

Researchers at the University of Pennsylvania have demonstrated that morphine withdrawal complicates hepatitis C by suppressing IFN-alpha-mediated immunity and enhancing virus replication. The paper ...

A recent study published in the journal Medical Clinics of North America discussed the diagnosis, treatment, and pathophysiology of alcoholic hepatitis (AH). AH is characterized by aggravating or ...

There are five kinds of hepatitis. Each has different causes, with one commonality: Hepatitis causes your liver to get inflamed. Hepatitis disease can also sometimes be spread through sexual contact.

Chronic hepatitis B is a growing worldwide public health issue. Its prevalence and the mode of transmission of the virus varies greatly between parts of the world. Prevalence is rising in the UK due ...

Dr. Chen Liu, recently named as the Anthony N. Brady Professor of Pathology, is an expert in viral hepatitis, liver cancer immunotherapy, graft-versus-host disease, and cancer epigenetics. His ...

Hepatitis, inflammation of your liver, is typically caused by five specific viruses. But the Epstein-Barr virus (EBV) that causes mononucleosis infection has also been linked to hepatitis. Hepatitis ...

Approximately 270-300 million people worldwide are infected with hepatitis C, and about 1%-2% of the U.S. population is infected. This infectious disease can lead to scarring of the liver, cirrhosis, ...

The Vaccine Integrity Project’s evidence review of the first dose of the hepatitis B vaccine will offer a transparent, ...